Latest news
Breathlessness can be sign of heart or lung disease: Expert - The Times of IndiaThe Times of India · Sat, 08 Aug 2026 19:50:00 GMTSanofi Pauses Phase 2 Trial of Monoclonal Antibody SAR445399 in Chronic Lung Disease - BioPharm InternationalBioPharm International · Thu, 06 Aug 2026 15:59:10 GMTStudy links cognitive function, hand dexterity to proper inhaler use in COPD - COPD News TodayCOPD News Today · Thu, 06 Aug 2026 02:16:19 GMTAzithromycin shows lower COPD flare-up rates over one year than roflumilast - Medical XpressMedical Xpress · Wed, 05 Aug 2026 20:40:05 GMTRecognizing Early ILD Symptoms Can Speed Up Diagnosis: Steven D. Nathan, MD - The American Journal of Managed CareThe American Journal of Managed Care · Wed, 05 Aug 2026 19:07:36 GMTSanofi suspends chronic lung disease phase 2 study, tied to ‘strategic business reasons’ - Fierce BiotechFierce Biotech · Wed, 05 Aug 2026 18:50:22 GMTA COPD drug from China draws $115M in venture funding - BioPharma DiveBioPharma Dive · Wed, 05 Aug 2026 13:19:45 GMTSanofi-backed Expedition uses $115M series B to advance COPD drug on phase 2 journey - Fierce BiotechFierce Biotech · Wed, 05 Aug 2026 12:02:58 GMT